Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome.

Saved in:
Bibliographic Details
Title: Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome.
Authors: Phithak E; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Albach FN; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Minopoulou I; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Biesen R; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Kleyer A; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism Research Centre (DRFZ) Berlin, a Leibnitz Institute, Berlin, Germany., Wiebe E; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Siegert E; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Scholz V; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Rehm M; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Cheng Q; German Rheumatism Research Centre (DRFZ) Berlin, a Leibnitz Institute, Berlin, Germany., Sattler A; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism Research Centre (DRFZ) Berlin, a Leibnitz Institute, Berlin, Germany., Bianco S; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Fleischmann A; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Hermann KG; Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Walter-Rittel T; Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Wagner M; Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Zernicke J; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Casteleyn V; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Nielsen M; Department of Rheumatology and Clinical Immunology, Immanuel Krankenhaus, Berlin, Germany., Rose T; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Busse A; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13092 Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, 10117 Berlin, Germany., Hütter-Krönke ML; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Keller U; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13092 Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, 10117 Berlin, Germany., Schneider U; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Department of Rheumatology and Clinical Immunology, Immanuel Krankenhaus, Berlin, Germany., Kawelke L; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Ruffer N; Division of Rheumatology and Systemic Inflammatory Diseases III, Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Stenzel W; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Krönke G; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism Research Centre (DRFZ) Berlin, a Leibnitz Institute, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology, Allergology and Immunology, Berlin, Germany., Simon D; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism Research Centre (DRFZ) Berlin, a Leibnitz Institute, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology, Allergology and Immunology, Berlin, Germany. Electronic address: david.simon@charite.de., Alexander T; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism Research Centre (DRFZ) Berlin, a Leibnitz Institute, Berlin, Germany.
Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2026 Jan; Vol. 85 (1), pp. 212-215. Date of Electronic Publication: 2025 Oct 23.
Publication Type: Letter
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1468-2060
DOI:10.1016/j.ard.2025.09.012